NCT05791539

Brief Summary

Post-thoracotomy pain is a challenging clinical problem that may be associated with increased morbidity and mortality. The current study tests two techniques of regional anaesthesia to control post thoracotomy pain

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 16, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

February 2, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

March 30, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 12, 2023

Completed
20 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2023

Completed
Last Updated

August 30, 2023

Status Verified

August 1, 2023

Enrollment Period

8 months

First QC Date

December 16, 2022

Last Update Submit

August 29, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Total amount of morphine consumption in the first 24-hour postoperative in the two groups.

    20ml for ESPB compared to 10ml ESPB added to 10ml RLB.

    24 hours

Secondary Outcomes (5)

  • •Pain score according to VAS score

    24 hours

  • • Heart rate

    intraoperative

  • Incidence of complications

    24 hours

  • .First request of analgesia postoperative

    24 hours

  • MAP

    intraoperative

Study Arms (3)

Group 1 Erector spinae plane block

EXPERIMENTAL

Group 1 (ESPB (control group): (n = 15) patients will receive preoperative US-guided ESPB on the operated side by 20 ml bupivacaine 0.25%.

Procedure: Erector spinae plane block

Group 2: Erector spinae plane block

EXPERIMENTAL

US-guided ESPB with 10 ml bupivacaine 0.25% (n = 15) on the operated side.

Procedure: Erector spinae plane block

Retro laminar block

EXPERIMENTAL

the US-guided retrolaminar block 10 ml bupivacaine 0.25% group: (n = 15) on the operated side.

Procedure: erector spinae plane block + retrolaminar block

Interventions

Patients will be divided into 2 groups group 1 will receive US-guided ESPB and group 2 will receive US-guided ESPB + US-guided Retrolaminar plain block before induction of GA.

Group 1 Erector spinae plane blockGroup 2: Erector spinae plane block

Patients will be divided into 2 groups group 1 will receive US-guided ESPB and group 2 will receive US-guided ESPB + US-guided Retrolaminar plain block before induction of GA.

Retro laminar block

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age from 18-65 years.
  • body mass index (BMI) ranged between 20 and 40 kg/m2

You may not qualify if:

  • Patient refusal.
  • Sensitivity or contraindication to local anesthetic drugs.
  • History of psychological disorders and/or chronic pain.
  • Localized infection at the site of the block.
  • Coagulopathies, patients on anticoagulants and antiplatelets, and significant liver or renal insufficiency

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo Unviersity

Cairo, Egypt

RECRUITING

Study Officials

  • sherif mamdouh, MD

    Cairo University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

sherif mamdouh, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
Randomization will be accomplished through the use of computer-generated random numbers and closed opaque envelopes. Another anesthesiologist who will not be involved in the other parts of the study will open the envelopes to enroll patients. and both patients and outcome assessors will be blinded to the assignment of groups.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

December 16, 2022

First Posted

March 30, 2023

Study Start

February 2, 2023

Primary Completion

October 12, 2023

Study Completion

November 1, 2023

Last Updated

August 30, 2023

Record last verified: 2023-08

Locations